The Leeds Innovation & Application Center is the newest of the now 71 Brenntag Specialties innovation centers globally, 31 of which focus on Food & Nutrition.
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Polyvantis has opened a new Technology Center in Shanghai, China, to unite R&D, commercial, and manufacturing teams and accelerate innovation for optical and electrical film solutions.
Henkel has doubled the size of its South Dakota plant to increase production of thermal management materials for the electric vehicle and electronics markets.
Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
BASF and cooperation partner GIG Karasek have celebrated the symbolic ground-breaking ceremony for one of the world's largest industrial heat pumps for CO2-free steam generation at the Ludwigshafen site.
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
Solvay strengthens its competitiveness in Germany through portfolio realignment and investments.
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Honeywell’s Quantinuum has raised $600 million at a $10 billion valuation, with Nvidia and other key investors backing the company to accelerate development of advanced quantum technologies and global partnerships.
Vioneo awards ECI Group contract to build world’s first LDPE plant using entirely fossil-free feedstock.
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
With the start-up of its production unit in Kentucky, Arkema develops its low Global Warming Potential (GWP) fluorospecialties to meet demand for more sustainable solutions in building insulation and thermal management.
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
Sumitomo Chemical has constructed and begun operation of a pilot facility at the Sodegaura site of its Chiba Works for its new proprietary process to produce propylene directly from ethanol.
Nouryon has signed a long-term agreement with Arauco for the supply of sodium chlorate and chlorine dioxide for Arauco's new $4.6 billion pulp mill in Mato Grosso do Sul, Brazil.
AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.
Chevron Phillips Chemical has successfully completed the expansion of its low-viscosity polyalphaolefins production unit in Beringen, Belgium, boosting its manufacturing capacity in Europe.
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.
Sygnature Discovery, an integrated drug discovery CRO, has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure following a £1 million investment.
AstraZeneca recently announced $50 billion of investment in the US by 2030. This investment is expected to create tens of thousands of new, highly skilled jobs nationwide.
Sanner, a provider of high-quality healthcare packaging and drug delivery solutions, officially opened its first US-based production facility in Greensboro, North Carolina.
Ineos has completed a major £30 million investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions.
The Flamma Group, a Contract Development and Manufacturing Organization (CDMO), recently celebrated the grand opening of a new cGMP plant in Dalian, China.
Arkema is building an additional unit at its Singapore site to produce Rilsan Clear, a transparent polyamide. With an investment of $20 million, the site is expected to open in early 2026.
In a new building at the Wacker Consortium, the company's central research site, researchers are working on new manufacturing processes for biopharmaceuticals and ingredients for food and nutritional supplements.
